Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIBOFLAVIN 5^-PHOSPHATE vs RIFAPENTINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIBOFLAVIN 5^-PHOSPHATE vs RIFAPENTINE: Safety Overview

Metric RIBOFLAVIN 5^-PHOSPHATE RIFAPENTINE
Total FAERS Reports 244 298
Deaths Reported 9 8
Death Rate 3.7% 2.7%
Hospitalizations 13 88
Average Patient Age 34.8 yrs 46.5 yrs
% Female Patients 39.6% 55.6%
FDA Approval Date N/A Jun 22, 1998
Manufacturer N/A sanofi-aventis U.S. LLC
Route N/A ORAL
Marketing Status N/A Prescription